RESÚMENES JULIO 2010

Tratamiento de Otros Trastornos Neuropsiquiátricos

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o estudio aleatorizado; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana

 

3 - Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?

Alessandro Martorana, Zaira Esposito & Giacomo Koch

CNS Neuroscience & Therapeutics. Volume 16 Issue 4, Pages 235 - 245

 

3 - Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease

Murat Emre, Roberto Bernabei, Rafael Blesa, Roger Bullock, Luis Cunha, Hugo Daniëls, Edward Dziadulewicz, Hans Förstl, Lutz Frölich, Tomasz Gabryelewicz, Oleg Levin, James Lindesay, Pablo Martínez-Lage, Andreas Monsch, Magda Tsolaki & Teus van Laar

CNS Neuroscience & Therapeutics. Volume 16 Issue 4, Pages 246 - 253

 

5< - Positive effects of repetitive transcranial magnetic stimulation on attention in ADHD Subjects: A randomized controlled pilot study

Y. Bloch, E.V. Harel, S. Aviram, J. Govezensky, G. Ratzoni & Y. Levkovitz

World Journal of Biological Psychiatry. August 2010, Vol. 11, No. 5 , Pages 755-758

 

4 - Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: Secondary analyses of four pooled randomized controlled trials of duloxetine




References and further reading may be available for this article. To view references and further reading you must
purchase this article.

Lauren B. Marangell, Daniel J. Clauw, Ernest Choy, Fujun Wang, Scarlett Shoemaker, Laurence Bradley, Philip Mease and Madelaine M. Wohlreich

Pain July 2010. Article in Press

 

3 - Dapoxetine: In Premature Ejaculation

Hoy, Sheridan M.; Scott, Lesley J

Drugs: 30 July 2010 - Volume 70 - Issue 11 - pp 1433-1443

 

3 - Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome

Prasad B, Radulovacki M, Olopade C, Herdegen JJ, Logan T, Carley DW

Sleep. 2010 Jul 1;33(7):982-9

 

5< - A Double-Blind, Placebo-Controlled Trial of Lamotrigine for Pathological Skin Picking: Treatment Efficacy and Neurocognitive Predictors of Response

Grant, Jon E; Odlaug, Brian L; Chamberlain, Samuel R; Kim, Suck Won

Journal of Clinical Psychopharmacology: August 2010 - Volume 30 - Issue 4 - pp 396-403

 

3 - Effect of Modafinil on Impairments in Neurobehavioral Performance and Learning Associated with Extended Wakefulness and Circadian Misalignment

Scott Grady, Daniel Aeschbach, Kenneth P Wright Jr and Charles A Czeisler

Neuropsychopharmacology (2010) 35, 1910–1920

 

3 - Management of tics and Tourette's disorder: an update

Durga Prasad Bestha, Shamala Jeevarakshagan & Vishal Madaan

Expert Opinion on Pharmacotherapy. August 2010, Vol. 11, No. 11 , Pages 1813-1822

 

4 - Treating Neuropsychiatric Symptoms in Dementia With Lewy Bodies: A Randomized Controlled-trial

Culo S, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, Houck PR, Pollock BG

Alzheimer Dis Assoc Disord. 2010 Jul 9. [Epub ahead of print]

 

3 - Longitudinal Medication Usage in Alzheimer Disease Patients

Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y

Alzheimer Dis Assoc Disord. 2010 Jul 9. [Epub ahead of print]

 

3! - Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy

Guillermo Gervasini, Julio Benítez and Juan Antonio Carrillo

European Journal of Clinical Pharmacology. Volume 66, Number 8, 755-774

 

3! - The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution

Eva Choong, Maria Dobrinas, Pierre-Alain Carrupt & Chin B Eap

Expert Opinion on Drug Metabolism & Toxicology. August 2010, Vol. 6, No. 8 , Pages 953-965

 

3 - Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease

Katharina Wulff, Silvia Gatti, Joseph G. Wettstein & Russell G. Foster

Nature Reviews Neuroscience 11, 589-599 (August 2010)

 

3 - A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients.

MacDonald K, Wilson MP, Minassian A, Vilke GM, Perez R, Cobb P, Tallian K, Becker O, Feifel D

Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):443-5. Epub 2010 Jun 12

 

GRATIS 3 - Armodafinil in the treatment of sleep/wake disorders

Jonathan RL Schwartz, Thomas Roth, Chris Drake

Neuropsychiatric Disease and Treatment. 2010;6:417 - 427

 

3 - A review of SSRIs and SNRIs in neuropathic pain

Yee-Chi Lee & Phoon-Ping Chen

Expert Opinion on Pharmacotherapy. Posted online on July 19, 2010

 

5 - Should We Expand the Toolbox of Psychiatric Treatment Methods to Include Repetitive Transcranial Magnetic Stimulation (rTMS)? A Meta-Analysis of the Efficacy of rTMS in Psychiatric Disorders

Christina W. Slotema, Jan Dirk Blom, Hans W. Hoek, and Iris E. C. Sommer

J Clin Psychiatry 2010;71(7):873–884

 

3 - Fibromyalgia syndrome: practical strategies for improving diagnosis and patient outcomes

Arnold LM, Clauw DJ

Am J Med. 2010 Jun;123(6):S2

 

3 - Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists

Krystal, John H; Mathew, Sanjay J; D'Souza, D. Cyril; Garakani, Amir; Gunduz-Bruce, Handan; Charney, Dennis S

CNS Drugs: 1 August 2010 - Volume 24 - Issue 8 - pp 669-693

 

3 - Low-Dose Doxepin: In the Treatment of Insomnia

Weber, Juliane; Siddiqui, M. Asif A; Wagstaff, Antona J; McCormack, Paul L

CNS Drugs: 1 August 2010 - Volume 24 - Issue 8 - pp 713-720

 

4 - Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease

Serge Gauthier, Oscar L. Lopez, Gunhild Waldemar, Roy W. Jones, Jeffrey Cummings, Richard Zhang, Rachel Schindler and Elias Schwam

International Psychogeriatrics (2010), 22:973-983

 

3 - Established Donepezil Treatment Modulates Regional Brain Activation in Early Alzheimer's Disease

W.J. McGeown, M.F. Shanks, K.E. Forbes-McKay, G.D. Waiter, I. Elrick, M.G. Venneri, A. Venneri

Current Alzheimer Research 2010;Volume 7 Issue 5: 415-427

3 - The Serum Protein and Lipid Oxidation Marker Levels in Alzheimer's Disease and Effects of Cholinesterase Inhibitors and Antipsychotic Drugs Therapy

F. Sinem, K. Dildar, E. Gokhan, B. Melda, Y. Orhan, M. Filiz

Current Alzheimer Research 2010; Volume 7 Issue 5: 463-469 

 


 



Regresar a RESÚMENES JULIO 2010


© 1999-2010 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA